source
- Thiel-backed Lindus Therapeutics sells CRO division and shifts focus to acquiring drug assetsLindus Therapeutics, a transatlantic startup backed by Peter Thiel, announced the sale of its contract research organization (CRO) arm. The company, previously positioning itself as an “anti‑CRO,”…
- FDA lifts clozapine monitoring requirements, easing use for children with schizophreniaThe Food and Drug Administration on Feb. 24, 2025 eliminated the long‑standing monitoring program that has governed clozapine for more than three decades. The change removes the extensive paperwork…